HYDROXYCHLOROQUINE SULFATE

HYDROXYCHLOROQUINE SULFATE was reported 91640 times

HYDROXYCHLOROQUINE SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 67 0.7701
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4832 0.6737
2 RED BLOOD CELL SEDIMENTATION RATE 181 0.6487
3 RHEUMATOID FACTOR POSITIVE 3635 0.6287
4 RHEUMATOID FACTOR NEGATIVE 109 0.6229
5 PEMPHIGUS 7519 0.6008
6 SWOLLEN JOINT COUNT INCREASED 1838 0.5758
7 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 379 0.5674
8 RHEUMATIC FEVER 2446 0.5482
9 DUODENAL ULCER PERFORATION 3944 0.5298
10 C-REACTIVE PROTEIN 489 0.5275
11 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 177 0.5268
12 LUPUS VULGARIS 662 0.5254
13 DEEP VEIN THROMBOSIS POSTOPERATIVE 1052 0.5252
14 HEPATIC ENZYME 78 0.5235
15 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1200 0.5204
16 HAND DEFORMITY 6758 0.5147
17 MUSCULOSKELETAL DEFORMITY 120 0.5128
18 GRIP STRENGTH 112 0.4891
19 SWOLLEN JOINT COUNT 122 0.4880
20 SYNOVITIS 8424 0.4667
21 C-REACTIVE PROTEIN ABNORMAL 2981 0.4643
22 GRANULOMA SKIN 364 0.4434
23 X-RAY ABNORMAL 735 0.4106
24 FACET JOINT SYNDROME 1298 0.3983
25 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 815 0.3930
26 DISLOCATION OF VERTEBRA 891 0.3903
27 HELICOBACTER INFECTION 3991 0.3879
28 ANTICIPATORY ANXIETY 102 0.3750
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2432 0.3741
30 MUSCLE INJURY 3089 0.3724
31 RETINITIS 563 0.3256
32 FOLLICULITIS 3412 0.3250
33 JOINT LAXITY 98 0.3245
34 BONE EROSION 1147 0.3240
35 CONTRAINDICATED PRODUCT ADMINISTERED 9728 0.3210
36 PRESBYACUSIS 98 0.3182
37 SERONEGATIVE ARTHRITIS 363 0.3168
38 GLOSSODYNIA 6968 0.3109
39 PERICARDITIS 5158 0.3067
40 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 170 0.3030
41 BLOOD PARATHYROID HORMONE DECREASED 426 0.2873
42 DRUG TOLERANCE DECREASED 806 0.2867
43 BODY HEIGHT BELOW NORMAL 180 0.2799
44 INTESTINAL SEPSIS 72 0.2748
45 RHEUMATOID NODULE 757 0.2746
46 ELBOW DEFORMITY 93 0.2688
47 PERIPHERAL VENOUS DISEASE 1043 0.2551
48 SYSTEMIC LUPUS ERYTHEMATOSUS 9038 0.2544
49 ANKLE ARTHROPLASTY 89 0.2452
50 HEART FAILURE WITH PRESERVED EJECTION FRACTION 72 0.2449
51 LOOSE BODY IN JOINT 62 0.2331
52 SLE ARTHRITIS 66 0.2324
53 RHEUMATOID LUNG 207 0.2168
54 HYPOCHOLESTEROLAEMIA 76 0.2153
55 BLOOD IRON ABNORMAL 209 0.2139
56 WOUND 5834 0.2085
57 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2218 0.2003
58 DISABILITY ASSESSMENT SCALE SCORE INCREASED 60 0.1954
59 WRIST DEFORMITY 119 0.1935
60 GRIP STRENGTH DECREASED 1631 0.1851
61 PANNICULITIS 440 0.1817
62 RHEUMATOID ARTHRITIS 20611 0.1814
63 JOINT DESTRUCTION 279 0.1793
64 BLOOD PRESSURE DIASTOLIC ABNORMAL 455 0.1787
65 BLOOD PRESSURE SYSTOLIC ABNORMAL 434 0.1754
66 PORPHYRIA ACUTE 241 0.1679
67 TENOSYNOVITIS 461 0.1670
68 BREAST CANCER STAGE III 1074 0.1657
69 ARTHROPATHY 8976 0.1613
70 IRRITABLE BOWEL SYNDROME 3434 0.1600
71 JOINT RANGE OF MOTION DECREASED 2129 0.1586
72 DEAFNESS TRANSITORY 135 0.1581
73 PLEURAL THICKENING 103 0.1506
74 C-REACTIVE PROTEIN DECREASED 95 0.1455
75 TENOSYNOVITIS STENOSANS 81 0.1454
76 THERAPEUTIC PRODUCT EFFECT DECREASED 6515 0.1453
77 ARTHRODESIS 147 0.1444
78 LIP DRY 1297 0.1427
79 NECK DEFORMITY 62 0.1396
80 BONE CYST 130 0.1386
81 ONYCHOMADESIS 573 0.1364
82 FIBROMYALGIA 3253 0.1337
83 SYNOVIAL DISORDER 60 0.1319
84 ONYCHOMYCOSIS 575 0.1309
85 DRUG INTOLERANCE 12522 0.1295
86 WOUND INFECTION 1415 0.1291
87 HYPERCHOLESTEROLAEMIA 1244 0.1287
88 BURSITIS 1563 0.1287
89 FINGER DEFORMITY 609 0.1256
90 ENTHESOPATHY 193 0.1233
91 MEAN PLATELET VOLUME DECREASED 101 0.1204
92 LIVE BIRTH 1007 0.1203
93 VASCULAR ACCESS COMPLICATION 96 0.1185
94 OVERLAP SYNDROME 81 0.1157
95 IMPAIRED HEALING 3799 0.1156
96 AUTOIMMUNE DISORDER 1107 0.1135
97 ALLERGY TO CHEMICALS 138 0.1108
98 SEROSITIS 61 0.1103
99 POLYARTHRITIS 575 0.1090
100 RETINAL TOXICITY 112 0.1087
101 LIVER INJURY 2632 0.1071
102 JUVENILE IDIOPATHIC ARTHRITIS 262 0.1070
103 ANTIBODY TEST POSITIVE 177 0.1066
104 BODY TINEA 59 0.1054
105 PLEURAL FIBROSIS 107 0.1050
106 JOINT SWELLING 12435 0.1029
107 SCIATICA 1596 0.1000
108 BLOOD MAGNESIUM INCREASED 90 0.0998
109 BLOODY DISCHARGE 113 0.0989
110 INFUSION RELATED REACTION 6559 0.0989
111 PSORIATIC ARTHROPATHY 4013 0.0988
112 HIP ARTHROPLASTY 1501 0.0979
113 C-REACTIVE PROTEIN INCREASED 3505 0.0962
114 BLEPHAROSPASM 603 0.0957
115 PULMONARY FIBROSIS 1837 0.0957
116 HEPATIC ENZYME INCREASED 6505 0.0953
117 TREATMENT FAILURE 7856 0.0947
118 DEATH NEONATAL 131 0.0941
119 FOOT DEFORMITY 1044 0.0941
120 MATERNAL EXPOSURE TIMING UNSPECIFIED 348 0.0926
121 NAIL DISORDER 786 0.0897
122 LUPUS NEPHRITIS 168 0.0897
123 SWELLING 8338 0.0890
124 TYPE 2 DIABETES MELLITUS 2951 0.0876
125 OBESITY 1396 0.0875
126 EXOSTOSIS 798 0.0873
127 LARYNGEAL DISORDER 63 0.0873
128 LOWER RESPIRATORY TRACT INFECTION 3916 0.0860
129 ALANINE AMINOTRANSFERASE ABNORMAL 180 0.0853
130 SHOULDER ARTHROPLASTY 228 0.0846
131 KNEE ARTHROPLASTY 1776 0.0843
132 DISCOMFORT 5115 0.0838
133 JOINT ARTHROPLASTY 146 0.0815
134 LUPUS-LIKE SYNDROME 721 0.0794
135 TUBERCULIN TEST POSITIVE 200 0.0789
136 SURGICAL FAILURE 91 0.0787
137 APPARENT DEATH 282 0.0782
138 OSTEOARTHRITIS 3280 0.0773
139 JOINT EFFUSION 532 0.0771
140 DRUG SPECIFIC ANTIBODY 103 0.0752
141 PUSTULAR PSORIASIS 258 0.0750
142 MEAN CELL VOLUME DECREASED 115 0.0745
143 LIMB DEFORMITY 118 0.0742
144 EPICONDYLITIS 112 0.0742
145 WALKING AID USER 489 0.0741
146 INFUSION SITE REACTION 219 0.0732
147 FINE MOTOR SKILL DYSFUNCTION 211 0.0728
148 SKIN NECROSIS 376 0.0724
149 MUSCULOSKELETAL STIFFNESS 6200 0.0707
150 BLISTER 3974 0.0707
151 INTERNATIONAL NORMALISED RATIO FLUCTUATION 146 0.0705
152 SYNOVIAL CYST 324 0.0701
153 BLOOD CHOLESTEROL INCREASED 3175 0.0680
154 STOMATITIS 4010 0.0661
155 MEAN CELL HAEMOGLOBIN DECREASED 121 0.0660
156 PRODUCT LABEL CONFUSION 376 0.0644
157 SOFT TISSUE DISORDER 71 0.0640
158 BUTTERFLY RASH 64 0.0631
159 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3019 0.0628
160 SPINAL STENOSIS 258 0.0624
161 PRESCRIBED OVERDOSE 1207 0.0623
162 INFLAMMATION 3186 0.0617
163 CREPITATIONS 183 0.0614
164 LOWER LIMB FRACTURE 1164 0.0605
165 MOBILITY DECREASED 4349 0.0605
166 MATERNAL EXPOSURE DURING PREGNANCY 5389 0.0604
167 DRUG TOLERANCE 299 0.0590
168 SPONDYLITIS 214 0.0588
169 ABDOMINAL DISCOMFORT 9834 0.0586
170 GAIT INABILITY 1958 0.0585
171 DEFORMITY 534 0.0571
172 JOINT DISLOCATION 602 0.0569
173 PRURITUS ALLERGIC 66 0.0566
174 LIVER FUNCTION TEST INCREASED 1212 0.0564
175 OCULAR TOXICITY 62 0.0562
176 BACK INJURY 605 0.0556
177 SCLERITIS 89 0.0555
178 COELIAC DISEASE 536 0.0546
179 ILL-DEFINED DISORDER 3305 0.0543
180 MUSCULOSKELETAL PAIN 2846 0.0543
181 BRONCHITIS CHRONIC 130 0.0532
182 JOINT STIFFNESS 1374 0.0523
183 NIGHT SWEATS 1683 0.0522
184 PRESCRIBED UNDERDOSE 1037 0.0519
185 NODULE 656 0.0502
186 ALOPECIA 9672 0.0492
187 SINUSITIS 5040 0.0491
188 GASTROINTESTINAL DISORDER 4368 0.0487
189 HEPATIC ENZYME ABNORMAL 242 0.0485
190 ULCER HAEMORRHAGE 328 0.0484
191 BLOOD PRESSURE DIASTOLIC INCREASED 221 0.0478
192 PLEURITIC PAIN 132 0.0478
193 PULMONARY TOXICITY 337 0.0476
194 FOOT OPERATION 235 0.0474
195 ANTINUCLEAR ANTIBODY POSITIVE 153 0.0470
196 WHEELCHAIR USER 208 0.0467
197 RHEUMATIC DISORDER 90 0.0465
198 EYE INJURY 141 0.0464
199 SPINAL COLUMN INJURY 103 0.0462
200 PERIPHERAL SWELLING 7073 0.0459
201 BREAST CANCER STAGE II 375 0.0450
202 VIRAL UPPER RESPIRATORY TRACT INFECTION 214 0.0450
203 SPINAL FUSION SURGERY 182 0.0448
204 CONGENITAL ANOMALY 345 0.0445
205 DISABILITY 875 0.0442
206 INVESTIGATION ABNORMAL 63 0.0438
207 BLOOD PRESSURE SYSTOLIC INCREASED 853 0.0437
208 COLITIS MICROSCOPIC 206 0.0435
209 PNEUMONIA VIRAL 138 0.0432
210 ADVERSE REACTION 571 0.0430
211 CUSHINGOID 138 0.0430
212 BLOOD PRESSURE DIASTOLIC DECREASED 317 0.0429
213 HEPATIC CIRRHOSIS 803 0.0427
214 MUSCULOSKELETAL DISORDER 797 0.0418
215 OSTEOPOROTIC FRACTURE 80 0.0418
216 RASH VESICULAR 200 0.0413
217 CUTANEOUS LUPUS ERYTHEMATOSUS 80 0.0411
218 TENDERNESS 420 0.0403
219 PHYSICAL DISABILITY 178 0.0402
220 HYPERSENSITIVITY 7416 0.0399
221 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2840 0.0399
222 SENSITIVITY TO WEATHER CHANGE 210 0.0399
223 LYME DISEASE 133 0.0399
224 BASAL CELL CARCINOMA 608 0.0389
225 ARTHRITIS 3050 0.0387
226 OSTEOSCLEROSIS 61 0.0387
227 LUNG DISORDER 1896 0.0386
228 INTENTIONAL PRODUCT USE ISSUE 3384 0.0386
229 NECK MASS 109 0.0385
230 INFECTION 5557 0.0384
231 DEAFNESS NEUROSENSORY 126 0.0383
232 DERMATOMYOSITIS 97 0.0382
233 EAR INFECTION 1018 0.0382
234 HYPERCALCAEMIA 455 0.0368
235 LIVER DISORDER 1630 0.0367
236 JOINT LOCK 103 0.0362
237 WHEEZING 2143 0.0361
238 MONOCYTE COUNT INCREASED 131 0.0360
239 THYROID NEOPLASM 99 0.0359
240 CONTUSION 3451 0.0358
241 EAR PAIN 696 0.0358
242 SLEEP DISORDER 2523 0.0357
243 INJURY 2511 0.0357
244 DRUG ERUPTION 633 0.0357
245 THERAPY NON-RESPONDER 1590 0.0353
246 ULCER 549 0.0345
247 OEDEMA 1871 0.0345
248 GENERAL PHYSICAL HEALTH DETERIORATION 3969 0.0343
249 ARTHRALGIA 14050 0.0338
250 DIVERTICULITIS 936 0.0337
251 BONE DENSITY ABNORMAL 126 0.0337
252 IMPAIRED WORK ABILITY 718 0.0336
253 BODY TEMPERATURE DECREASED 329 0.0334
254 ADRENAL INSUFFICIENCY 403 0.0332
255 OSTEOPOROSIS 1361 0.0331
256 PREGNANCY 655 0.0327
257 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 557 0.0325
258 INFLAMMATORY MARKER INCREASED 160 0.0322
259 NORMAL NEWBORN 175 0.0322
260 SKIN ULCER 832 0.0322
261 DRUG-INDUCED LIVER INJURY 1007 0.0321
262 BLOOD PRESSURE FLUCTUATION 767 0.0319
263 ROAD TRAFFIC ACCIDENT 1327 0.0317
264 NASOPHARYNGITIS 5828 0.0316
265 MYOSITIS 282 0.0314
266 EXPOSURE DURING PREGNANCY 1948 0.0313
267 FUNCTIONAL GASTROINTESTINAL DISORDER 108 0.0312
268 INFECTION SUSCEPTIBILITY INCREASED 67 0.0306
269 LOSS OF EMPLOYMENT 91 0.0301
270 MUSCLE SPASTICITY 368 0.0299
271 HEPATITIS 752 0.0294
272 PRODUCT USE ISSUE 5518 0.0293
273 FEAR OF INJECTION 209 0.0293
274 PHARYNGITIS 362 0.0292
275 HEPATOTOXICITY 649 0.0291
276 CONDITION AGGRAVATED 8823 0.0290
277 JOINT INJURY 619 0.0289
278 EPIGASTRIC DISCOMFORT 113 0.0289
279 RED CELL DISTRIBUTION WIDTH INCREASED 120 0.0289
280 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 68 0.0286
281 NECK PAIN 1562 0.0279
282 DELIRIUM 968 0.0279
283 RESPIRATORY DISORDER 822 0.0274
284 PAIN 16841 0.0274
285 GENERAL SYMPTOM 204 0.0272
286 HERPES ZOSTER 1563 0.0272
287 FIBROSIS 83 0.0269
288 TASTE DISORDER 538 0.0265
289 GRANULOMA 91 0.0263
290 SINUS PAIN 61 0.0261
291 UPPER RESPIRATORY TRACT INFECTION 1190 0.0257
292 TONGUE DISORDER 183 0.0253
293 INTERSTITIAL LUNG DISEASE 1223 0.0252
294 ENDODONTIC PROCEDURE 64 0.0252
295 HEPATIC FIBROSIS 86 0.0250
296 RASH 10890 0.0250
297 DRUG USE DISORDER 210 0.0250
298 TERMINAL STATE 167 0.0249
299 ARTHRITIS INFECTIVE 115 0.0248
300 THERAPEUTIC RESPONSE DECREASED 1490 0.0245
301 SPINAL COLUMN STENOSIS 116 0.0245
302 MOUTH ULCERATION 511 0.0242
303 LOCALISED INFECTION 586 0.0242
304 DRY MOUTH 1957 0.0241
305 CUTANEOUS VASCULITIS 88 0.0241
306 PULMONARY MASS 356 0.0239
307 IMMOBILE 104 0.0238
308 ARTHRITIS BACTERIAL 97 0.0236
309 CARPAL TUNNEL SYNDROME 329 0.0235
310 BRONCHIECTASIS 157 0.0233
311 PULMONARY THROMBOSIS 253 0.0232
312 WEIGHT INCREASED 5193 0.0232
313 BODY TEMPERATURE INCREASED 473 0.0232
314 GASTROINTESTINAL PAIN 255 0.0232
315 HYPERTENSION 4881 0.0230
316 SKIN PAPILLOMA 92 0.0229
317 IMMUNODEFICIENCY 342 0.0229
318 CONFUSIONAL STATE 3683 0.0228
319 RETINOPATHY 85 0.0228
320 PHOTOSENSITIVITY REACTION 376 0.0227
321 BREATH SOUNDS ABNORMAL 112 0.0227
322 MULTIPLE ALLERGIES 178 0.0227
323 INTERVERTEBRAL DISC DEGENERATION 210 0.0227
324 DRUG INEFFECTIVE 29383 0.0223
325 SKIN LACERATION 242 0.0222
326 MATERNAL EXPOSURE BEFORE PREGNANCY 152 0.0222
327 DYSPEPSIA 2179 0.0221
328 EPILEPSY 673 0.0220
329 DEMYELINATION 90 0.0219
330 PLEURISY 130 0.0219
331 HEPATIC STEATOSIS 407 0.0218
332 MIGRAINE 2081 0.0218
333 HYPOAESTHESIA 3260 0.0218
334 URTICARIA 3614 0.0216
335 PAIN IN EXTREMITY 6290 0.0213
336 SARCOIDOSIS 101 0.0212
337 INJECTION SITE HAEMATOMA 307 0.0211
338 IRON DEFICIENCY 95 0.0211
339 GLAUCOMA 405 0.0210
340 BRONCHITIS 1543 0.0208
341 LIMB OPERATION 99 0.0206
342 GASTROINTESTINAL TOXICITY 99 0.0206
343 BACK DISORDER 332 0.0204
344 INFUSION SITE PRURITUS 64 0.0203
345 VASCULITIS 236 0.0202
346 ADVERSE DRUG REACTION 1816 0.0202
347 TENDON DISORDER 131 0.0201
348 TRIGGER FINGER 82 0.0200
349 OSTEOPENIA 303 0.0199
350 ADVERSE EVENT 1818 0.0197
351 RASH PRURITIC 1065 0.0196
352 SPUTUM DISCOLOURED 184 0.0194
353 SPINAL OSTEOARTHRITIS 170 0.0193
354 INJECTION SITE REACTION 1331 0.0193
355 BONE LESION 69 0.0191
356 TENDONITIS 296 0.0191
357 FOOD INTOLERANCE 70 0.0191
358 SKIN REACTION 269 0.0191
359 CYST 237 0.0191
360 INFUSION SITE HAEMORRHAGE 62 0.0188
361 DRUG EFFECT INCOMPLETE 682 0.0188
362 POOR VENOUS ACCESS 194 0.0187
363 ESCHERICHIA URINARY TRACT INFECTION 79 0.0186
364 ORAL DISORDER 136 0.0185
365 FATIGUE 14367 0.0184
366 WEIGHT FLUCTUATION 193 0.0184
367 SKIN WARM 106 0.0182
368 EYE DISORDER 598 0.0182
369 SECRETION DISCHARGE 226 0.0180
370 FOOT FRACTURE 342 0.0180
371 GASTRIC DISORDER 612 0.0178
372 MUSCULOSKELETAL DISCOMFORT 306 0.0178
373 MACULOPATHY 63 0.0177
374 VITAMIN D DEFICIENCY 172 0.0176
375 OSTEOMYELITIS 319 0.0176
376 INJECTION SITE IRRITATION 224 0.0176
377 FEMUR FRACTURE 544 0.0175
378 PLATELET COUNT INCREASED 228 0.0175
379 INFUSION SITE SWELLING 110 0.0175
380 BONE DISORDER 318 0.0174
381 ABDOMINAL PAIN UPPER 3572 0.0173
382 SCLERODERMA 63 0.0173
383 LIMB DISCOMFORT 524 0.0169
384 DERMATITIS ALLERGIC 213 0.0169
385 ORAL HERPES 328 0.0168
386 AMNESIA 1093 0.0168
387 CATARACT 1000 0.0168
388 INTERVERTEBRAL DISC PROTRUSION 365 0.0167
389 TOOTH INFECTION 220 0.0167
390 GAIT DISTURBANCE 3190 0.0167
391 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 282 0.0166
392 GASTROENTERITIS VIRAL 298 0.0165
393 THYROID DISORDER 254 0.0165
394 IRON DEFICIENCY ANAEMIA 152 0.0165
395 ANKYLOSING SPONDYLITIS 217 0.0164
396 RESPIRATORY RATE INCREASED 146 0.0164
397 BONE DENSITY DECREASED 515 0.0164
398 SINUS CONGESTION 222 0.0164
399 MUSCULAR WEAKNESS 1862 0.0164
400 ROSACEA 76 0.0163
401 VAGINAL INFECTION 76 0.0161
402 HEART RATE DECREASED 566 0.0161
403 LIVER FUNCTION TEST ABNORMAL 465 0.0160
404 OXYGEN SATURATION DECREASED 898 0.0160
405 POST PROCEDURAL INFECTION 129 0.0158
406 PAIN IN JAW 446 0.0157
407 ROTATOR CUFF SYNDROME 201 0.0156
408 ASTHMA 1765 0.0156
409 DRY EYE 779 0.0156
410 MENINGITIS 104 0.0156
411 STRESS FRACTURE 84 0.0156
412 ABNORMAL LOSS OF WEIGHT 106 0.0155
413 LYMPHOMA 240 0.0155
414 ATELECTASIS 150 0.0155
415 DRUG EFFECT DECREASED 836 0.0155
416 SUSPECTED OFF LABEL USE 70 0.0155
417 SHOULDER OPERATION 66 0.0154
418 PNEUMONIA 4987 0.0154
419 HYPERTRANSAMINASAEMIA 106 0.0152
420 RASH MACULO-PAPULAR 339 0.0152
421 GASTROOESOPHAGEAL REFLUX DISEASE 1221 0.0152
422 ORAL DISCOMFORT 210 0.0151
423 GOITRE 61 0.0149
424 PELVIC FRACTURE 116 0.0149
425 RESPIRATORY TRACT INFECTION 384 0.0147
426 TOOTH ABSCESS 150 0.0147
427 HAEMATOCRIT DECREASED 291 0.0147
428 LIGAMENT SPRAIN 145 0.0146
429 PYELONEPHRITIS 127 0.0146
430 PYREXIA 5068 0.0146
431 PHOTOPHOBIA 275 0.0146
432 NERVE COMPRESSION 134 0.0145
433 MULTIPLE FRACTURES 237 0.0144
434 OEDEMA PERIPHERAL 1757 0.0144
435 TOOTH FRACTURE 158 0.0143
436 ALANINE AMINOTRANSFERASE INCREASED 878 0.0143
437 SKIN INFECTION 160 0.0142
438 IMMUNOSUPPRESSION 125 0.0142
439 INTERVERTEBRAL DISC DISORDER 60 0.0140
440 HYPERKERATOSIS 77 0.0139
441 RESPIRATORY TRACT CONGESTION 221 0.0139
442 UPPER-AIRWAY COUGH SYNDROME 114 0.0138
443 MENISCUS INJURY 85 0.0138
444 ANAPHYLACTIC REACTION 762 0.0138
445 GLUCOSE TOLERANCE IMPAIRED 81 0.0137
446 ORAL CANDIDIASIS 180 0.0137
447 SPINAL COMPRESSION FRACTURE 113 0.0137
448 PRURITUS 5242 0.0136
449 SPINAL DISORDER 129 0.0136
450 FEEDING DISORDER 276 0.0136
451 RALES 79 0.0136
452 CHEST PAIN 2513 0.0136
453 GROIN PAIN 119 0.0135
454 POSTOPERATIVE WOUND INFECTION 91 0.0135
455 HEADACHE 8443 0.0135
456 MALAISE 5888 0.0134
457 SEASONAL ALLERGY 190 0.0134
458 BLOOD PRESSURE SYSTOLIC DECREASED 61 0.0134
459 INFUSION SITE ERYTHEMA 113 0.0134
460 SKIN LESION 367 0.0134
461 DIVERTICULUM 95 0.0134
462 EYE INFECTION 150 0.0133
463 INFUSION SITE PAIN 171 0.0133
464 CANDIDA INFECTION 223 0.0132
465 KIDNEY INFECTION 259 0.0132
466 MEDICATION ERROR 733 0.0132
467 FOETAL GROWTH RESTRICTION 80 0.0131
468 OFF LABEL USE 11521 0.0131
469 ACCIDENT 157 0.0131
470 ECCHYMOSIS 90 0.0131
471 CYSTITIS 416 0.0131
472 INSOMNIA 3478 0.0130
473 UPPER LIMB FRACTURE 260 0.0130
474 LEUKOPENIA 648 0.0129
475 WHITE BLOOD CELL COUNT INCREASED 497 0.0129
476 FLANK PAIN 121 0.0129
477 SKIN MASS 86 0.0129
478 ASPARTATE AMINOTRANSFERASE INCREASED 684 0.0129
479 ANKLE FRACTURE 199 0.0128
480 DENTAL CARIES 142 0.0128
481 BREAST MASS 86 0.0128
482 MEMORY IMPAIRMENT 1757 0.0128
483 FREQUENT BOWEL MOVEMENTS 345 0.0128
484 PRODUCTIVE COUGH 608 0.0127
485 TOOTH DISORDER 281 0.0126
486 VOMITING 5933 0.0126
487 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 98 0.0126
488 DECREASED APPETITE 2901 0.0125
489 CATARACT OPERATION 74 0.0125
490 LABORATORY TEST ABNORMAL 368 0.0125
491 UVEITIS 169 0.0124
492 SINUS HEADACHE 74 0.0124
493 GASTROINTESTINAL INFECTION 111 0.0124
494 PURPURA 109 0.0123
495 MASS 172 0.0123
496 CELLULITIS 618 0.0123
497 PARAESTHESIA 1923 0.0122
498 BLOOD IRON DECREASED 145 0.0122
499 WEIGHT DECREASED 3411 0.0122
500 HERPES VIRUS INFECTION 70 0.0121
501 NASAL CONGESTION 714 0.0121
502 DRUG SPECIFIC ANTIBODY PRESENT 79 0.0121
503 NAUSEA 9604 0.0121
504 OROPHARYNGEAL PAIN 1123 0.0121
505 TONSILLITIS 63 0.0121
506 PHARYNGOLARYNGEAL PAIN 64 0.0120
507 RASH PUSTULAR 87 0.0119
508 INJECTION SITE WARMTH 245 0.0119
509 HERNIA 230 0.0119
510 RHINORRHOEA 765 0.0118
511 DEAFNESS 309 0.0118
512 RED BLOOD CELL COUNT DECREASED 337 0.0118
513 QUALITY OF LIFE DECREASED 158 0.0118
514 IMMUNE SYSTEM DISORDER 155 0.0117
515 VISUAL IMPAIRMENT 1453 0.0117
516 ORAL PAIN 262 0.0117
517 PERIPHERAL VASCULAR DISORDER 60 0.0116
518 DIARRHOEA 7478 0.0116
519 LOW BIRTH WEIGHT BABY 92 0.0116
520 PRODUCT USE IN UNAPPROVED INDICATION 2861 0.0115
521 INCREASED TENDENCY TO BRUISE 106 0.0115
522 POOR QUALITY SLEEP 247 0.0115
523 SQUAMOUS CELL CARCINOMA 108 0.0115
524 INJECTION SITE PRURITUS 764 0.0114
525 FUNGAL INFECTION 378 0.0113
526 RENAL CYST 90 0.0113
527 MUSCLE STRAIN 98 0.0113
528 DYSPNOEA 6400 0.0113
529 ANAL FISSURE 60 0.0112
530 BLOOD PRESSURE INCREASED 1706 0.0111
531 MYOPATHY 96 0.0111
532 ARTHROPOD BITE 82 0.0111
533 TOOTHACHE 200 0.0110
534 ONYCHOCLASIS 76 0.0110
535 DEPRESSION 2509 0.0110
536 HYSTERECTOMY 95 0.0110
537 INFLUENZA 1216 0.0109
538 GASTRIC ULCER 206 0.0108
539 LYMPHADENOPATHY 383 0.0108
540 TYPE 1 DIABETES MELLITUS 65 0.0108
541 NEPHROLITHIASIS 495 0.0108
542 VIRAL INFECTION 358 0.0107
543 ASTHENIA 4032 0.0107
544 BACK PAIN 2488 0.0107
545 LIMB INJURY 289 0.0106
546 HYPERLIPIDAEMIA 127 0.0106
547 PROTEINURIA 202 0.0106
548 ABDOMINAL PAIN 2461 0.0106
549 WRIST FRACTURE 126 0.0105
550 LOCAL SWELLING 183 0.0105
551 MUSCLE SPASMS 1925 0.0105
552 PHARYNGITIS STREPTOCOCCAL 113 0.0104
553 SEPTIC SHOCK 451 0.0104
554 CONJUNCTIVITIS 191 0.0103
555 DYSSTASIA 300 0.0103
556 STAPHYLOCOCCAL INFECTION 338 0.0102
557 ABSCESS 163 0.0102
558 NEURALGIA 248 0.0102
559 ELECTROCARDIOGRAM QT PROLONGED 366 0.0102
560 COUGH 2836 0.0101
561 LUNG INFECTION 157 0.0101
562 APHTHOUS ULCER 78 0.0100
563 PSORIASIS 1304 0.0100
564 VISUAL FIELD DEFECT 72 0.0100
565 MALIGNANT MELANOMA 133 0.0099
566 OVARIAN CYST 99 0.0099
567 POST PROCEDURAL COMPLICATION 189 0.0098
568 URINARY TRACT INFECTION 1678 0.0098
569 FLUID RETENTION 500 0.0098
570 APHONIA 137 0.0098
571 GASTROENTERITIS 142 0.0097
572 RIB FRACTURE 199 0.0097
573 STENT PLACEMENT 78 0.0097
574 DRY THROAT 98 0.0096
575 PHARYNGEAL SWELLING 94 0.0096
576 FURUNCLE 76 0.0096
577 BLOOD ALBUMIN DECREASED 76 0.0096
578 MITRAL VALVE INCOMPETENCE 108 0.0095
579 HIATUS HERNIA 123 0.0095
580 DIABETES MELLITUS 724 0.0095
581 INJECTION SITE RASH 291 0.0095
582 VITAMIN D DECREASED 81 0.0095
583 IMPAIRED GASTRIC EMPTYING 129 0.0095
584 FACIAL PAIN 84 0.0094
585 SCAR 161 0.0094
586 RECTAL HAEMORRHAGE 403 0.0094
587 DIZZINESS 4676 0.0094
588 CARDIAC MURMUR 81 0.0094
589 BEDRIDDEN 123 0.0093
590 EAR DISCOMFORT 96 0.0093
591 CARDIOMYOPATHY 138 0.0093
592 IMPAIRED QUALITY OF LIFE 134 0.0093
593 FEELING HOT 571 0.0093
594 ABDOMINAL DISTENSION 968 0.0093
595 DERMATITIS 193 0.0092
596 INJECTION SITE ERYTHEMA 1142 0.0092
597 HAND FRACTURE 65 0.0092
598 SCRATCH 96 0.0091
599 INJECTION SITE SWELLING 697 0.0091
600 SINUS DISORDER 180 0.0091
601 DEEP VEIN THROMBOSIS 590 0.0091
602 INJECTION SITE EXTRAVASATION 112 0.0091
603 FALL 3021 0.0091
604 COLITIS ULCERATIVE 405 0.0091
605 GENERALISED OEDEMA 111 0.0090
606 SPINAL PAIN 105 0.0090
607 THROAT IRRITATION 402 0.0090
608 RHINITIS 72 0.0089
609 PANCREATITIS 468 0.0088
610 SPINAL OPERATION 109 0.0088
611 PULMONARY HYPERTENSION 184 0.0088
612 HEART RATE INCREASED 873 0.0088
613 CLOSTRIDIUM DIFFICILE INFECTION 192 0.0088
614 UROSEPSIS 81 0.0088
615 HAEMOGLOBIN DECREASED 901 0.0088
616 HYPERAESTHESIA 72 0.0088
617 UNDERDOSE 632 0.0086
618 MUSCULOSKELETAL CHEST PAIN 134 0.0086
619 SKIN DISORDER 288 0.0086
620 LACERATION 81 0.0086
621 BLOOD TEST ABNORMAL 121 0.0086
622 TRANSAMINASES INCREASED 191 0.0086
623 GOUT 153 0.0085
624 EMPHYSEMA 86 0.0085
625 INJECTION SITE BRUISING 676 0.0085
626 HYPOKALAEMIA 391 0.0085
627 HYPOPHAGIA 216 0.0084
628 TRICUSPID VALVE INCOMPETENCE 67 0.0084
629 DYSPNOEA EXERTIONAL 316 0.0084
630 PREMATURE DELIVERY 133 0.0083
631 THROMBOSIS 670 0.0083
632 CHOLECYSTECTOMY 95 0.0083
633 MOVEMENT DISORDER 267 0.0083
634 EYE PAIN 467 0.0083
635 INJECTION SITE URTICARIA 203 0.0083
636 SKIN HYPERPIGMENTATION 71 0.0083
637 MACULAR DEGENERATION 98 0.0082
638 NEUTROPHIL COUNT INCREASED 84 0.0082
639 NERVE INJURY 91 0.0082
640 NEOPLASM MALIGNANT 545 0.0082
641 GINGIVAL BLEEDING 111 0.0081
642 HYPOKINESIA 118 0.0081
643 AGRANULOCYTOSIS 150 0.0081
644 ERYTHEMA 1655 0.0080
645 FEELING JITTERY 153 0.0080
646 GALLBLADDER DISORDER 143 0.0080
647 PNEUMONITIS 218 0.0080
648 PHARYNGEAL OEDEMA 123 0.0080
649 HYPOCALCAEMIA 151 0.0080
650 TEMPERATURE INTOLERANCE 82 0.0079
651 TENDON RUPTURE 98 0.0079
652 SPINAL FRACTURE 159 0.0079
653 DERMATITIS CONTACT 89 0.0078
654 ESCHERICHIA INFECTION 64 0.0078
655 SLEEP APNOEA SYNDROME 148 0.0077
656 BURNING SENSATION 543 0.0077
657 WHITE BLOOD CELL COUNT DECREASED 838 0.0077
658 EYE HAEMORRHAGE 103 0.0077
659 BLOOD POTASSIUM DECREASED 232 0.0077
660 SEPSIS 850 0.0076
661 EJECTION FRACTION DECREASED 118 0.0076
662 SKIN PLAQUE 64 0.0076
663 ILLNESS 781 0.0076
664 BACTERIAL INFECTION 141 0.0076
665 TOXIC SKIN ERUPTION 76 0.0075
666 INJECTION SITE PAIN 2308 0.0075
667 INSURANCE ISSUE 115 0.0075
668 BLOOD POTASSIUM INCREASED 122 0.0075
669 SNEEZING 168 0.0075
670 LOSS OF CONSCIOUSNESS 959 0.0075
671 INJECTION SITE INDURATION 97 0.0075
672 BLOOD CREATININE INCREASED 488 0.0075
673 BLADDER DISORDER 74 0.0074
674 BODY HEIGHT DECREASED 79 0.0074
675 INJECTION SITE DISCOLOURATION 92 0.0074
676 EATING DISORDER 155 0.0073
677 INFLUENZA LIKE ILLNESS 593 0.0072
678 BLOOD PRESSURE ABNORMAL 143 0.0072
679 RASH ERYTHEMATOUS 342 0.0071
680 SKIN CANCER 154 0.0071
681 NEUROPATHY PERIPHERAL 679 0.0071
682 BLOOD URINE PRESENT 135 0.0071
683 RESTLESS LEGS SYNDROME 129 0.0071
684 FOETAL EXPOSURE DURING PREGNANCY 575 0.0071
685 CARDIOMEGALY 87 0.0071
686 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 369 0.0071
687 PNEUMOCYSTIS JIROVECII PNEUMONIA 71 0.0071
688 PLEURAL EFFUSION 430 0.0071
689 HIP FRACTURE 227 0.0071
690 ABORTION INDUCED 66 0.0070
691 COVID-19 1226 0.0070
692 ANXIETY 1985 0.0070
693 THROAT TIGHTNESS 188 0.0069
694 SKIN DISCOLOURATION 319 0.0069
695 SWELLING FACE 451 0.0069
696 SKIN SWELLING 60 0.0069
697 TOOTH EXTRACTION 86 0.0069
698 PERICARDIAL EFFUSION 159 0.0069
699 DISEASE RECURRENCE 327 0.0069
700 MYALGIA 1168 0.0069
701 MIDDLE INSOMNIA 127 0.0068
702 SUPRAVENTRICULAR TACHYCARDIA 65 0.0068
703 PULMONARY ARTERIAL HYPERTENSION 98 0.0068
704 DYSPHONIA 395 0.0067
705 TACHYCARDIA 598 0.0067
706 ACTIVITIES OF DAILY LIVING IMPAIRED 133 0.0067
707 HAEMORRHOIDS 131 0.0067
708 COVID-19 PNEUMONIA 79 0.0067
709 CARDIAC FAILURE CONGESTIVE 535 0.0067
710 CHEST DISCOMFORT 681 0.0066
711 CHILLS 777 0.0066
712 GASTRITIS 174 0.0066
713 KNEE OPERATION 65 0.0066
714 CLOSTRIDIUM DIFFICILE COLITIS 70 0.0066
715 PULMONARY EMBOLISM 622 0.0065
716 PREMATURE BABY 197 0.0065
717 DECREASED ACTIVITY 70 0.0065
718 EYE DISCHARGE 67 0.0064
719 ERYTHEMA MULTIFORME 60 0.0064
720 GASTRIC HAEMORRHAGE 74 0.0064
721 DECREASED IMMUNE RESPONSIVENESS 63 0.0064
722 HYPOTHYROIDISM 205 0.0064
723 OCULAR DISCOMFORT 72 0.0064
724 FRACTURE 120 0.0063
725 BLOOD ALKALINE PHOSPHATASE INCREASED 157 0.0063
726 HEPATOMEGALY 62 0.0063
727 FULL BLOOD COUNT ABNORMAL 66 0.0062
728 HYPERTENSIVE CRISIS 69 0.0062
729 SURGERY 363 0.0062
730 RENAL IMPAIRMENT 519 0.0062
731 INTENTIONAL DOSE OMISSION 176 0.0062
732 SKIN FISSURES 120 0.0061
733 SCAB 70 0.0061
734 OESOPHAGITIS 67 0.0061
735 PROCEDURAL PAIN 170 0.0061
736 HEART RATE IRREGULAR 138 0.0061
737 FEELING ABNORMAL 1463 0.0061
738 GLOMERULAR FILTRATION RATE DECREASED 75 0.0061
739 MUSCLE ATROPHY 77 0.0061
740 THYROID CANCER 73 0.0061
741 PNEUMOTHORAX 96 0.0060
742 CORONARY ARTERY OCCLUSION 83 0.0060
743 MOTOR DYSFUNCTION 61 0.0060
744 TINNITUS 275 0.0060
745 THERAPY PARTIAL RESPONDER 93 0.0060
746 GAMMA-GLUTAMYLTRANSFERASE INCREASED 132 0.0060
747 PALPITATIONS 697 0.0059
748 HEPATOCELLULAR INJURY 84 0.0059
749 PRESYNCOPE 143 0.0059
750 ACUTE RESPIRATORY DISTRESS SYNDROME 104 0.0059
751 UNEVALUABLE EVENT 443 0.0058
752 PERIPHERAL COLDNESS 80 0.0058
753 RENAL DISORDER 270 0.0058
754 LIP SWELLING 192 0.0058
755 VENTRICULAR TACHYCARDIA 95 0.0057
756 RENAL FAILURE 759 0.0057
757 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1025 0.0057
758 LYMPHOPENIA 80 0.0057
759 COLITIS 212 0.0056
760 CAESAREAN SECTION 65 0.0056
761 INJECTION SITE HAEMORRHAGE 439 0.0055
762 RASH MACULAR 192 0.0055
763 HAEMATOCHEZIA 303 0.0055
764 HYPOTENSION 1100 0.0055
765 SYNCOPE 548 0.0055
766 PRURITUS GENERALISED 118 0.0055
767 RASH PAPULAR 122 0.0054
768 ABASIA 134 0.0054
769 THERAPEUTIC RESPONSE SHORTENED 178 0.0054
770 CHOLELITHIASIS 176 0.0054
771 VERTIGO 326 0.0053
772 OCULAR HYPERAEMIA 253 0.0053
773 TREATMENT NONCOMPLIANCE 291 0.0053
774 LYMPHOCYTE COUNT DECREASED 94 0.0053
775 PARALYSIS 76 0.0053
776 HAEMOPTYSIS 146 0.0052
777 POLLAKIURIA 217 0.0052
778 HYPOAESTHESIA ORAL 78 0.0052
779 SARS-COV-2 TEST POSITIVE 68 0.0051
780 ACUTE RESPIRATORY FAILURE 99 0.0051
781 PARAESTHESIA ORAL 74 0.0051
782 HAEMATURIA 175 0.0051
783 ANAPHYLACTIC SHOCK 131 0.0051
784 TRANSIENT ISCHAEMIC ATTACK 171 0.0051
785 THIRST 90 0.0050
786 HYPOXIA 177 0.0050
787 PULMONARY CONGESTION 66 0.0050
788 HOT FLUSH 377 0.0050
789 MYOCARDIAL INFARCTION 867 0.0050
790 NEUTROPENIA 675 0.0050
791 WRONG TECHNIQUE IN DRUG USAGE PROCESS 180 0.0049
792 FAECES DISCOLOURED 107 0.0049
793 BLOOD SODIUM DECREASED 93 0.0049
794 SINUS TACHYCARDIA 70 0.0049
795 EYE IRRITATION 283 0.0049
796 PULMONARY OEDEMA 218 0.0049
797 HEAD INJURY 154 0.0049
798 EYE SWELLING 180 0.0048
799 RASH GENERALISED 125 0.0048
800 PRODUCT QUALITY ISSUE 654 0.0048
801 HAIR TEXTURE ABNORMAL 64 0.0048
802 PRODUCT DOSE OMISSION IN ERROR 134 0.0047
803 FEAR 127 0.0047
804 HYPOGLYCAEMIA 229 0.0047
805 ANAEMIA 900 0.0047
806 HYPERHIDROSIS 606 0.0047
807 PRODUCT PRESCRIBING ERROR 112 0.0047
808 DYSPHAGIA 446 0.0047
809 PANCYTOPENIA 262 0.0047
810 THROMBOCYTOPENIA 522 0.0047
811 DIPLOPIA 121 0.0047
812 FLUSHING 473 0.0046
813 CHROMATURIA 105 0.0046
814 CRYING 169 0.0046
815 STEVENS-JOHNSON SYNDROME 103 0.0046
816 BRONCHOSPASM 66 0.0046
817 VISION BLURRED 635 0.0046
818 LACRIMATION INCREASED 139 0.0046
819 HOSPITALISATION 703 0.0046
820 ANGIOEDEMA 202 0.0046
821 BONE PAIN 267 0.0046
822 BREAST CANCER 422 0.0045
823 SKIN HAEMORRHAGE 67 0.0045
824 RESPIRATORY FAILURE 329 0.0045
825 ECZEMA 236 0.0045
826 ORTHOSTATIC HYPOTENSION 78 0.0045
827 INCORRECT PRODUCT ADMINISTRATION DURATION 97 0.0045
828 ABORTION SPONTANEOUS 179 0.0045
829 CORONARY ARTERY DISEASE 134 0.0044
830 BRAIN FOG 69 0.0044
831 DYSURIA 162 0.0044
832 TOOTH LOSS 91 0.0044
833 FEELING COLD 122 0.0044
834 MYELODYSPLASTIC SYNDROME 63 0.0044
835 BLOOD PRESSURE DECREASED 289 0.0043
836 HEAD DISCOMFORT 77 0.0043
837 BALANCE DISORDER 375 0.0043
838 EOSINOPHILIA 76 0.0043
839 ATRIAL FIBRILLATION 422 0.0043
840 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 237 0.0043
841 ABDOMINAL PAIN LOWER 109 0.0043
842 INCREASED APPETITE 82 0.0043
843 EPISTAXIS 321 0.0043
844 ASCITES 126 0.0043
845 INTESTINAL OBSTRUCTION 161 0.0043
846 DRUG RESISTANCE 109 0.0042
847 PLATELET COUNT DECREASED 450 0.0042
848 BLINDNESS 172 0.0042
849 CHOLESTASIS 81 0.0042
850 HAEMATOMA 109 0.0042
851 OSTEONECROSIS 138 0.0042
852 SOMNOLENCE 844 0.0042
853 ARRHYTHMIA 198 0.0042
854 DEHYDRATION 555 0.0042
855 RETCHING 88 0.0041
856 PALLOR 112 0.0041
857 SPEECH DISORDER 215 0.0041
858 PANCREATITIS ACUTE 92 0.0041
859 MUCOSAL INFLAMMATION 107 0.0041
860 COLD SWEAT 72 0.0041
861 URINARY INCONTINENCE 121 0.0041
862 ANGINA PECTORIS 117 0.0041
863 BLOOD UREA INCREASED 68 0.0041
864 SENSORY DISTURBANCE 65 0.0040
865 PANIC ATTACK 146 0.0040
866 BLOOD LACTATE DEHYDROGENASE INCREASED 63 0.0040
867 DEVICE RELATED INFECTION 61 0.0040
868 CARDIAC FAILURE 318 0.0040
869 PRODUCT AVAILABILITY ISSUE 89 0.0039
870 DEPRESSED MOOD 206 0.0039
871 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100 0.0039
872 LEUKOCYTOSIS 70 0.0039
873 FACE OEDEMA 65 0.0039
874 PRODUCT DOSE OMISSION ISSUE 1123 0.0038
875 THINKING ABNORMAL 71 0.0038
876 INTENTIONAL PRODUCT MISUSE 333 0.0038
877 HYPERSOMNIA 109 0.0038
878 PELVIC PAIN 69 0.0038
879 HAEMATEMESIS 96 0.0038
880 SWOLLEN TONGUE 118 0.0038
881 DRUG INTERACTION 599 0.0038
882 CARDIAC DISORDER 352 0.0038
883 LUNG NEOPLASM MALIGNANT 153 0.0037
884 PERITONITIS 77 0.0037
885 SKIN EXFOLIATION 313 0.0037
886 MUSCLE TIGHTNESS 60 0.0037
887 MOOD SWINGS 118 0.0037
888 RENAL FAILURE ACUTE 157 0.0037
889 BLOOD GLUCOSE ABNORMAL 67 0.0036
890 CARDIOVASCULAR DISORDER 92 0.0036
891 CHRONIC KIDNEY DISEASE 274 0.0036
892 PAIN OF SKIN 97 0.0036
893 DYSARTHRIA 135 0.0036
894 INJECTION SITE MASS 132 0.0036
895 THERAPEUTIC RESPONSE UNEXPECTED 160 0.0036
896 LETHARGY 204 0.0035
897 BLOOD CREATINE PHOSPHOKINASE INCREASED 101 0.0035
898 PRODUCT DOSE OMISSION 229 0.0035
899 TREMOR 581 0.0035
900 FLATULENCE 194 0.0034
901 INTERNATIONAL NORMALISED RATIO INCREASED 96 0.0034
902 THERAPY INTERRUPTED 236 0.0033
903 DEVICE MALFUNCTION 232 0.0033
904 CONSTIPATION 717 0.0033
905 DYSGEUSIA 244 0.0033
906 CEREBROVASCULAR ACCIDENT 553 0.0033
907 ACNE 247 0.0033
908 NERVOUSNESS 170 0.0033
909 VISUAL ACUITY REDUCED 108 0.0032
910 HYPOACUSIS 139 0.0032
911 RESPIRATORY DISTRESS 89 0.0032
912 BLOOD BILIRUBIN INCREASED 87 0.0032
913 APHASIA 97 0.0032
914 EYE PRURITUS 107 0.0032
915 HAEMORRHAGE 325 0.0031
916 HYPERKALAEMIA 109 0.0031
917 NERVOUS SYSTEM DISORDER 97 0.0031
918 DRUG DOSE OMISSION 513 0.0031
919 ACUTE MYOCARDIAL INFARCTION 91 0.0031
920 BREAST CANCER FEMALE 81 0.0030
921 EMOTIONAL DISORDER 93 0.0030
922 MENTAL STATUS CHANGES 83 0.0030
923 PRODUCT DISPENSING ERROR 65 0.0030
924 TOXICITY TO VARIOUS AGENTS 502 0.0030
925 DRY SKIN 382 0.0029
926 VAGINAL HAEMORRHAGE 124 0.0029
927 EXPOSURE VIA SKIN CONTACT 74 0.0029
928 ACUTE KIDNEY INJURY 431 0.0028
929 INCORRECT DOSE ADMINISTERED 633 0.0028
930 THERAPY CESSATION 142 0.0028
931 PHARMACEUTICAL PRODUCT COMPLAINT 71 0.0027
932 MULTIPLE SCLEROSIS 128 0.0027
933 SUICIDAL IDEATION 242 0.0026
934 DEVICE ISSUE 236 0.0026
935 COGNITIVE DISORDER 122 0.0026
936 DISEASE PROGRESSION 309 0.0026
937 DISORIENTATION 103 0.0026
938 NEEDLE ISSUE 75 0.0026
939 NIGHTMARE 89 0.0026
940 AGEUSIA 64 0.0026
941 OVERDOSE 552 0.0026
942 GASTROINTESTINAL HAEMORRHAGE 211 0.0025
943 MOOD ALTERED 67 0.0025
944 MENTAL DISORDER 106 0.0024
945 URINARY RETENTION 81 0.0024
946 CARDIAC ARREST 199 0.0024
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 171 0.0024
948 ACCIDENTAL OVERDOSE 87 0.0024
949 JAUNDICE 63 0.0023
950 MULTIPLE ORGAN DYSFUNCTION SYNDROME 66 0.0023
951 SEIZURE 268 0.0023
952 HEPATIC FUNCTION ABNORMAL 86 0.0023
953 DRUG DEPENDENCE 369 0.0023
954 DRUG EXPOSURE DURING PREGNANCY 78 0.0023
955 BLOOD GLUCOSE DECREASED 110 0.0023
956 NEUTROPHIL COUNT DECREASED 93 0.0023
957 HYPONATRAEMIA 127 0.0023
958 HEPATIC FAILURE 67 0.0022
959 BRADYCARDIA 117 0.0022
960 PSYCHOTIC DISORDER 64 0.0022
961 SKIN IRRITATION 97 0.0021
962 HALLUCINATION 159 0.0021
963 HYPERGLYCAEMIA 76 0.0021
964 BLOOD GLUCOSE INCREASED 392 0.0021
965 NO ADVERSE EVENT 375 0.0021
966 DISTURBANCE IN ATTENTION 109 0.0020
967 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 68 0.0020
968 CONVULSION 111 0.0019
969 COMA 89 0.0019
970 MYELOSUPPRESSION 67 0.0019
971 DYSKINESIA 75 0.0018
972 PRODUCT SUBSTITUTION ISSUE 106 0.0018
973 CARDIO-RESPIRATORY ARREST 74 0.0018
974 SKIN BURNING SENSATION 124 0.0017
975 DEVICE DISLOCATION 72 0.0017
976 AGITATION 121 0.0016
977 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 326 0.0016
978 IRRITABILITY 95 0.0016
979 SUICIDE ATTEMPT 92 0.0015
980 ACCIDENTAL EXPOSURE TO PRODUCT 155 0.0015
981 DERMATITIS ATOPIC 75 0.0014
982 DEATH 1127 0.0013
983 INTENTIONAL OVERDOSE 78 0.0012
984 EMOTIONAL DISTRESS 141 0.0012
985 FEBRILE NEUTROPENIA 76 0.0011
986 PRODUCT STORAGE ERROR 97 0.0011
987 PROSTATE CANCER 75 0.0009
988 COMPLETED SUICIDE 73 0.0009
989 DRUG ABUSE 66 0.0008
990 DRUG WITHDRAWAL SYNDROME 61 0.0007